Painless gastroscopy
Conditions
Interventions
experimental group:Remifentanil (0.4-0.6ug/kg) intravenous injection, and then etomidate (0.15-0.2ml/kg) were injected intravenously until the patients fell asleep. If the length of inspection time in
control group:Remifentanil (0.4-0.6ug/kg) intravenous injection, and then propofol (2-2.5ml/kg) were injected intravenously until the patients fell asleep. If the length of inspection time increases,
Sponsors
Department of Gastroenterology, Research Institute of Field Surgery, Daping Hospital, Third Military Medical University
Eligibility
Sex/Gender
All
Age
60 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Male or female, between 60-80 years old, intends to conduct a painless gastroscope inspection; (2) To be diagnosed according to the American Society Of Anesthesiologists physical status I-III; (3) To be able to answer the questionnaire survey correctly; (4) To be able to joine this study after signed the informed consents.
Exclusion criteria
Exclusion criteria: (1) Serious heart, lung, liver, kidney and metabolic diseases, electrolyte imbalance; (2) Blood pressure>180/110mmHg; (3) Patients with known allergy to emulsions or opioid medicines; (4) Electrocardiogram shows that II degree atrioventricular block or complete left bundle branch block, frequent ventricular premature; (5) Acute bronchitis or acute exacerbation of chronic bronchitis; (6) Severe airway obstruction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Pressure;oxyhemoglobin saturation;Heart rate;the time of examination;the awake time;The time that patients meet the standard to leave; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of adverse reactions;Medical expenses;Satisfaction: the anesthesiologist, the operating; | — |
Countries
China
Contacts
Public ContactLan Chunhui
Outcome results
None listed